The device rapidly reduces the parasitaemia of severe Malaria patients who have been hospitalised and prescribed IV drug treatment.
While there are effective pharmaceutical treatments available, disease severity, recovery times and mortality are all strongly linked to a patient’s parasitaemia upon beginning drug treatment. Given the lengthy travel time required for many developing world patients to reach hospital many only get treatment once it’s too late. The key to tackling malaria lies in our ability to facilitate the rapid removal of infected red blood cells. When this is successfully carried out, a significant reduction of parasitaemia occurs – and that signifies the first steps on a patient's road to recovery.